[1]
“Seroprevalence of Toxoplasmosis Antibodies among Diabetes Mellitus Patients and Assessment some Biochemical Markers”, IHJPAS, vol. 2017, no. IHSCICONF, pp. 539–551, May 2018, doi: 10.30526/2017.IHSCICONF.1880.